1371597-67-9

Upstream product

• 55727-49-6 3-chloro-6,7,8,9-tetrahydropyrrolo[2,1-b]quinazolin-11-one 
• 1371597-65-7 (E)-3-(4-aminobenzylidene)-6-chloro-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one 
• 625-36-5 2-chloropropionyl chloride 

Downstream Products

• 1371597-71-5 (E)-N-(4-((6-chloro-9-oxo-1,2-dihydropyrrolo[2,1-b]quinazolin-3(9H)-ylidene)methyl)phenyl)-3-(pyrrolidin-1-yl)propanamide 
• 1371597-73-7 (E)-N-(4-((6-chloro-9-oxo-1,2-dihydropyrrolo[2,1-b]quinazolin-3(9H)-ylidene)methyl)phenyl)-3-(piperidin-1-yl)propanamide 
• 1371597-69-1 (E)-1-(3-((4-((6-chloro-9-oxo-1,2-dihydropyrrolo[2,1-b]quinazolin-3(9H)-ylidene)methyl)phenyl)amino)-3-oxopropyl)pyridin-1-ium chloride 
• 1371597-72-6 (E)-N-(4-((6-chloro-9-oxo-1,2-dihydropyrrolo[2,1-b]quinazolin-3(9H)-ylidene)methyl)phenyl)-3-(diethylamino)propanamide 

Relevant academic research and scientific papers

Design, synthesis and evaluation of isaindigotone derivatives as dual inhibitors for acetylcholinesterase and amyloid beta aggregation

A series of isaindigotone derivatives and analogues were designed, synthesized and evaluated as dual inhibitors of cholinesterases (ChEs) and self-induced β-amyloid (Aβ) aggregation. The synthetic compounds had IC50 values at micro or nano molar range for cholinesterase inhibition, and some compounds exhibited strong inhibitory activity for AChE and high selectivity for AChE over BuChE, which were much better than the isaindigotone derivatives previously reported by our group. Most of these compounds showed higher self-induced Aβ aggregation inhibitory activity than a reference compound curcumin. The structure-activity relationship studies revealed that the derivatives with higher inhibition activity on AChE also showed higher selectivity for AChE over BuChE. Compound 6c exhibiting excellent inhibition for both AChE and self-induced Aβ aggregation was further studied using CD, EM, molecular docking and kinetics.